NDC codes

FDA NDC Directory
Product NDC (as listed)0169-2200Labeler and product segments. Claims need a package NDC.
Product NDC at billing width00169-2200Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
0169-2200-1100169220011001692200111 VIAL, GLASS in 1 CARTON (0169-2200-11) / 10 mL in 1 VIAL, GLASSMarketed from Jul 1, 2021

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
NovoLog Mix 70/30
Generic name (nonproprietary)
insulin aspart
Active ingredients
Insulin aspart — 100 [iU]/mL
Dosage form
Injection, Suspension
Route
Subcutaneous
Labeler
Novo Nordisk Pharmaceutical Industries, LPNDC labeler code 0169
Product type
Prescription drug
Marketing category
BLA — Biologics License ApplicationApplication BLA 021172
Marketing start
Listing expires
Other FDA classes
Insulin (Chemical structure)
Identifiers
Product ID 0169-2200_f999a4d9-129e-4cb2-88cb-2a855468882fSPL ID f999a4d9-129e-4cb2-88cb-2a855468882f
Pharmacologic class
Insulin Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400169220011 followed by a unit qualifier and the quantity

Package 00169-2200-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 0169-2200

What is NDC 0169-2200?
0169-2200 is the product NDC for NovoLog Mix 70/30 (insulin aspart), Insulin aspart 100 [iU]/mL injection, suspension, listed with the FDA by Novo Nordisk Pharmaceutical Industries, LP. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
NovoLog Mix 70/30 (Insulin aspart).
What is the active ingredient?
Insulin aspart.
Who is the labeler?
Novo Nordisk Pharmaceutical Industries, LP, NDC labeler code 0169. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for NovoLog Mix 70/30?
5 other product NDCs are listed under this name. See all NovoLog Mix 70/30 NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other NovoLog Mix 70/30 NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
NovoLog Mix 70/30insulin aspartInsulin aspart 100 [iU]/mLInjection, SuspensionSubcutaneousREMEDYREPACK INC.70518-211970518-2119-00
NovoLog Mix 70/30insulin aspartInsulin aspart 100 [iU]/mLInjection, SuspensionSubcutaneousNovo Nordisk Pharmaceutical Industries, LP0169-220100169-2201-25
NovoLog Mix 70/30insulin aspartInsulin aspart 100 [iU]/mLInjection, SuspensionSubcutaneousNovo Nordisk Pharmaceutical Industries, LP0169-369600169-3696-19
NovoLog Mix 70/30insulin aspartInsulin aspart 100 [iU]/mLInjection, SuspensionSubcutaneousA-S Medication Solutions50090-227250090-2272-00
NovoLog Mix 70/30insulin aspartInsulin aspart 100 [iU]/mLInjection, SuspensionSubcutaneousNovo Nordisk Pharmaceutical Industries, LP0169-368500169-3685-12

Other NDCs under BLA 021172

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BLA 021172
ProductStrengthForm · routeLabelerProduct NDC
.Insulin Aspart Protamine and Insulin Aspartinsulin aspartInsulin aspart 100 [iU]/mLInjection, SuspensionSubcutaneousA-S Medication Solutions50090-4959
Insulin Aspart Protamine and Insulin Aspart Mix 70/30insulin aspartInsulin aspart 100 [iU]/mLInjection, SuspensionSubcutaneousREMEDYREPACK INC.70518-3236
Insulin Aspart Protamine and Insulin Aspart Mix 70/30insulin aspartInsulin aspart 100 [iU]/mLInjection, SuspensionSubcutaneousNovo Nordisk Pharma, Inc.73070-200
Insulin Aspart Protamine and Insulin Aspart Mix 70/30insulin aspartInsulin aspart 100 [iU]/mLInjection, SuspensionSubcutaneousNovo Nordisk Pharma, Inc.73070-203
NovoLog Mix 70/30insulin aspartInsulin aspart 100 [iU]/mLInjection, SuspensionSubcutaneousNovo Nordisk Pharmaceutical Industries, LP0169-2201
NovoLog Mix 70/30insulin aspartInsulin aspart 100 [iU]/mLInjection, SuspensionSubcutaneousNovo Nordisk Pharmaceutical Industries, LP0169-3685
NovoLog Mix 70/30insulin aspartInsulin aspart 100 [iU]/mLInjection, SuspensionSubcutaneousNovo Nordisk Pharmaceutical Industries, LP0169-3696
NovoLog Mix 70/30insulin aspartInsulin aspart 100 [iU]/mLInjection, SuspensionSubcutaneousA-S Medication Solutions50090-2272
NovoLog Mix 70/30insulin aspartInsulin aspart 100 [iU]/mLInjection, SuspensionSubcutaneousREMEDYREPACK INC.70518-2119

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in